NCT06729125

Transcranial Photobiomodulation With Patients With Parkinson's Disease

Posture Stability and Functional Activity Changes After Transcranial Photobiomodulation for Patients With Parkinson's Disease: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: Al-Zaytoonah University of Jordan · Academic / Other
• Sex: All
• Age: 50 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. It is a progressive and disabling disease with significative impact on quality of life. Since it has no cure, available treatment is targeted to improve the symptoms due to a lack of dopamine in the central nervous system. The aim of the study was to see how transcranial photobiomodulation (tPBM) helped patients with Parkinson's disease.

Conditions

• Parkinson Disease

Interventions

Type	Name	Description
DEVICE	transcranial photobiomodulation	Single-session transcranial laser stimulation was administered with a continuous-wave, 1,064-nm laser (Model CG-5000 Laser, Cell Gen Therapeutics LLC, Dallas, TX).
OTHER	exercises training	balance exercises and others

Timeline

• Start date: 2024-12-15
• Primary completion: 2025-03-20
• Completion: 2025-04-03
• First posted: 2024-12-11
• Last updated: 2025-04-08

Locations

1 site across 1 country: Jordan